Discover the flourishing Europe CBD market projected to grow at a 24.57% CAGR by 2028. Legalization and increasing acceptance drive the market's expansion.

Snapshot img

Cannabidiol (CBD) Market Size 2025-2029

The cannabidiol (CBD) market size is forecast to increase by USD 56.5 billion, at a CAGR of 24.8% between 2024 and 2029.

The CBD market is experiencing significant growth, driven primarily by the ongoing legalization and regulatory changes surrounding cannabidiol. This evolving regulatory landscape presents both opportunities and challenges for market participants. On the one hand, increasing legalization allows for broader market access, fostering growth in various end-use industries such as food and beverages, cosmetics, and pharmaceuticals. On the other hand, the high cost of CBD products poses a significant challenge for consumer adoption and market penetration. The e-commerce industry plays a crucial role in the CBD market's growth, enabling brands to reach a wider audience and offering consumers the convenience of purchasing products online.
However, the high cost of CBD products, largely due to production and extraction expenses, may limit market expansion and create barriers for smaller players. To capitalize on market opportunities and navigate challenges effectively, companies must focus on optimizing production costs, exploring alternative extraction methods, and developing innovative, competitively priced products. By addressing these challenges and leveraging the growing demand for CBD, businesses can position themselves for success in this dynamic and rapidly evolving market.

What will be the Size of the Cannabidiol (CBD) Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The CBD market continues to evolve at an unprecedented pace, with new developments and trends emerging constantly. One of the most significant areas of growth is product differentiation, as companies strive to distinguish themselves in a crowded marketplace. CBD for inflammation is a popular application, with many brands offering various forms of CBD, including capsules, gummies, and topicals. Cannabis-derived CBD and hemp-derived CBD are two distinct categories, each with its unique advantages and challenges. The legal framework surrounding CBD is also a dynamic factor, with regulations evolving to accommodate the growing industry. Bioavailability is another critical aspect, with brands investing in research to improve the efficacy of their products through advanced formulation and delivery methods.

Consumer education is essential as the market becomes more complex, with various CBD types, such as broad spectrum and full spectrum, and different extraction methods, such as CO2 and ethanol. Brand awareness and loyalty are also crucial, with companies focusing on sustainable practices, transparency, and competitive pricing strategies to attract and retain customers. CBD's applications extend beyond human health, with the pet market showing significant growth. Pricing strategies vary, with some brands adopting a direct-to-consumer model, while others rely on retail channels and wholesale distribution. Regulations continue to shape the industry, with a focus on ensuring safety and quality, particularly in the areas of labeling, clinical trials, and intellectual property.

The CBD market's continuous evolution reflects the ongoing research and innovation in this field. From CBD oil to CBD vape products, CBD for anxiety to CBD for athletes, the potential applications of CBD are vast and ever-expanding. As the industry matures, it is essential to stay informed about the latest trends, regulations, and consumer preferences to remain competitive and succeed in this dynamic market.

How is this Cannabidiol (CBD) Industry segmented?

The cannabidiol (CBD) industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Source

  Marijuana
  Hemp


Distribution Channel

  Offline
  Online


End-user

  Medical
  Personal use
  Wellness


Geography

  North America

    US
    Canada
    Mexico


  Europe

    France
    Germany
    UK


  APAC

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

.

By Source Insights

The marijuana segment is estimated to witness significant growth during the forecast period.

CBD, a non-psychoactive compound derived from the cannabis plant, has gained significant attention in the health and wellness industry due to its potential therapeutic benefits. Different forms of CBD products cater to various consumer preferences, including capsules, oils, topicals, edibles, vape products, and tinctures. The market for CBD continues to grow rapidly, driven by increasing consumer awareness and acceptance, favorable legal frameworks, and expanding product inno

It is projected that Germany's medical cannabis market will exceed *********** U.S. dollars by 2027, making it the largest national medical cannabis market in Europe. By then, most European countries are expected to have legalized medical cannabis.

Europe CBD Product market size is USD 2344.56 million in 2024 and will expand at a compound annual growth rate (CAGR) of 14.7% from 2024 to 2031.

The global cannabidiol (CBD) supplements market is experiencing robust growth, driven by increasing consumer awareness of CBD's potential health benefits and the expanding legalization of cannabis-derived products. While precise market size figures for 2025 weren't provided, considering a conservative estimate based on recent market reports and projected CAGR, we can assume a 2025 market value of approximately $5 billion. This substantial market is expected to grow at a Compound Annual Growth Rate (CAGR) of 18% from 2025 to 2033, reaching an estimated value exceeding $15 billion by 2033. Key drivers include the rising prevalence of chronic pain, anxiety, and sleep disorders, along with increasing acceptance of alternative medicine approaches. Furthermore, the growing availability of CBD products in various formats, such as oils, capsules, edibles, and topicals, is fueling market expansion. The market is segmented by product type, distribution channel, and geographic region, with North America currently dominating due to early adoption and favorable regulatory environments. However, Europe and Asia-Pacific are emerging as significant markets, exhibiting strong growth potential. While challenges exist, such as regulatory uncertainty in certain regions and concerns about product quality and standardization, the overall outlook for the CBD supplements market remains exceptionally positive. The strong growth trajectory is further supported by the increasing number of companies entering the market. Key players like Kazmira, Freedom Leaf, Medical Marijuana, Folium Biosciences, Cannavest, Pharmahemp, CBD American Shaman, Select Oil, Canopy Growth Corporation, Aphria, and Whistler are actively shaping the market landscape through product innovation, strategic partnerships, and expanding distribution networks. The competitive intensity is likely to intensify as more players enter and consolidate within this rapidly evolving market segment. The ongoing research into the therapeutic properties of CBD is also contributing to market expansion, as new applications and benefits are discovered and validated. This positive outlook, combined with consumer demand, points toward sustained market expansion throughout the forecast period.

In Europe Cannabidiol Market, The European Industrial Hemp Association (EIHA) decided to take action after the Czech Ministry of Agriculture announced its intention to prohibit CBD-containing goods.

Europe Legal Cannabis Market is estimated to be USD 107.0 Billion by 2035 and is anticipated to register a CAGR of 23.47% during the forecast period And Growth Forecast 2035

Europe Cannabis Market has valued at USD 5.02 Billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.53% through 2028.

Europe Cannabidiol Market is expected to grow at a high CAGR during the forecast period 2023-2030 | DataM Intelligence

The global cannabidiol (CBD) market is experiencing robust growth, projected to reach $567.2 million in 2025 and exhibiting a remarkable Compound Annual Growth Rate (CAGR) of 27.1% from 2025 to 2033. This expansion is driven by several factors. Increasing consumer awareness of CBD's potential therapeutic benefits for anxiety, pain relief, and sleep disorders fuels demand across diverse applications. The legalization and decriminalization of cannabis in various regions are significantly contributing to market accessibility. Furthermore, the expanding research and development efforts focused on CBD's efficacy and safety profile are further boosting investor confidence and driving market growth. The market's segmentation reflects this diverse application landscape, with significant contributions from the pharmaceuticals, food, and cosmetics industries. Hemp-derived CBD currently dominates the market due to its legal accessibility and lower cost compared to marijuana-derived CBD. However, the latter segment is expected to witness significant growth as regulations evolve. Key players such as Kazmira, KND Labs, and Aurora Cannabis are actively shaping the market through product innovation and strategic expansions. The geographic distribution of the CBD market reflects a concentration in North America, initially driven by early adoption and supportive regulatory environments in the United States and Canada. However, growing acceptance in Europe and the Asia-Pacific region, particularly in countries with emerging cannabis regulations, presents substantial untapped potential. While challenges remain, such as inconsistent regulations across different jurisdictions and concerns regarding product quality and standardization, the overall market outlook for CBD remains exceptionally positive, driven by continuous innovation, expanding consumer base, and the potential for broad therapeutic applications. The market is expected to continue its trajectory of strong growth well into the forecast period (2025-2033), benefiting from technological advancements and growing consumer understanding of CBD's diverse applications.

Europe CBD Beverages Market size is USD 1355.46 million in 2024 and will expand at a compound annual growth rate (CAGR) of 22.7% from 2024 to 2031.

In 2023, the medical cannabis market in Europe was valued at approximately 745 million U.S. dollars. In the following years, as more European countries will introduce legalization, the market is expected to increase significantly. Forecasts show that by 2027, the market could reach around 2.2 billion U.S. dollars.

The Cannabidiol (CBD) Oil Market Report is Segmented by Source Type (Hemp-Derived, Marijuana-Derived), Product Form (Capsules & Softgels and More), Sales Type (B2B, B2C [Offline Retail Pharmacies and More]), End-Use Sector (Cosmetics & Beauty and More), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Cannabidiol (CBD) Market Outlook

As per our latest research, the global Cannabidiol (CBD) market size in 2024 reached USD 9.4 billion, reflecting a robust expansion in the wellness and medical sectors. The industry is projected to maintain a strong growth trajectory with a CAGR of 21.2% from 2025 to 2033. By the end of 2033, the CBD market is forecasted to attain a value of USD 62.8 billion. The primary growth factor is the accelerating adoption of CBD-based products across a diverse range of end-user industries, underpinned by increasing consumer awareness and evolving regulatory frameworks worldwide.

The growth of the Cannabidiol (CBD) market is significantly propelled by the increasing legalization and decriminalization of cannabis and hemp-derived products in various regions. As governments across North America, Europe, and parts of Latin America ease regulatory restrictions, manufacturers are able to introduce innovative CBD products into the mainstream market. Consumers are rapidly gravitating towards natural and plant-based therapeutic options, with CBD products gaining traction for their purported benefits in pain management, anxiety relief, and chronic disease mitigation. The proliferation of research on CBD’s efficacy, coupled with endorsements from medical professionals and wellness influencers, further accelerates consumer acceptance, driving the market’s upward momentum.

Another key driver for the Cannabidiol (CBD) market is the surge in demand from the pharmaceutical and nutraceutical sectors. CBD’s non-psychoactive profile and its potential therapeutic properties have positioned it as a promising ingredient in the formulation of drugs and dietary supplements. Pharmaceutical companies are investing in clinical trials to validate the safety and efficacy of CBD-based medications for conditions such as epilepsy, multiple sclerosis, and sleep disorders. Simultaneously, the nutraceutical industry is leveraging CBD in functional foods and beverages, capitalizing on consumer trends favoring preventive healthcare and holistic wellness. This cross-sectoral integration is fostering a dynamic market landscape and expanding the application scope of CBD.

Technological advancements in extraction and processing methods are also playing a pivotal role in the growth of the Cannabidiol (CBD) market. Innovations such as CO2 extraction and nanoemulsion technology are enabling manufacturers to produce high-purity, bioavailable, and consistent CBD formulations. These advancements not only improve product quality but also enhance scalability and cost-efficiency for producers. Moreover, the expansion of distribution channels, particularly the rise of e-commerce and direct-to-consumer platforms, has made CBD products more accessible to a global audience. This omnichannel approach is breaking down barriers to entry, allowing both established players and new entrants to reach a wider customer base.

Regionally, North America continues to dominate the Cannabidiol (CBD) market, accounting for the largest share in 2024. The United States, in particular, benefits from a progressive regulatory environment, a well-established supply chain, and high consumer awareness. Europe is rapidly emerging as a lucrative market, driven by regulatory harmonization and increasing investments in research and development. The Asia Pacific region is witnessing growing interest, especially in countries like Australia, Japan, and South Korea, where regulatory reforms are underway. Latin America and the Middle East & Africa are gradually opening up, presenting untapped opportunities for market expansion as local governments reconsider their stance on cannabinoid products.

Product Type Analysis

The CBD market by product type is characterized by a diverse array of offerings, including CBD oil, CBD isolates, CBD tinctures, CBD capsules, CBD topicals, and others. Among these, CBD oil holds the largest m

The global medicinal grade cannabis market is experiencing robust growth, driven by increasing legalization and acceptance of cannabis for therapeutic purposes, coupled with advancements in research and development of cannabis-based medications. The market, currently estimated at $15 billion in 2025, is projected to exhibit a Compound Annual Growth Rate (CAGR) of 18% from 2025 to 2033, reaching an estimated value of $60 billion by 2033. This significant expansion is fueled by several key factors. Rising prevalence of chronic pain, anxiety, and other conditions responsive to cannabinoid therapies is a major driver. Furthermore, the expanding range of cannabis-derived products, encompassing dronabinol, nabilone, nabiximols, and cannabidiol (CBD), caters to a diverse patient population and treatment needs. The market's segmentation across applications – hospitals, clinics, and pharmacies – reflects the increasing integration of medicinal cannabis into mainstream healthcare systems. Technological advancements in cultivation and extraction methods are also contributing to market growth by improving product quality and consistency. However, regulatory hurdles, varying legal frameworks across different regions, and concerns regarding the long-term effects of cannabis use continue to pose challenges to market expansion. Strict regulations on cannabis cultivation and distribution, coupled with the need for extensive clinical trials to establish efficacy and safety, can impede market penetration. The lack of standardized quality control protocols and inconsistent pricing across the market can also affect consumer confidence. Despite these constraints, the long-term outlook for the medicinal grade cannabis market remains exceptionally positive, fueled by ongoing research, evolving regulations, and a growing acceptance of cannabis as a viable therapeutic option. The increasing number of companies involved in the cultivation, processing, and distribution of medicinal cannabis further indicates its growing significance in the global healthcare landscape. This in-depth report provides a comprehensive overview of the burgeoning medicinal grade cannabis market, projected to reach $15 billion by 2028. We delve into concentration levels, market trends, key players, and future growth potential, providing actionable insights for businesses and investors. The report leverages extensive market research and data analysis to deliver a detailed picture of this dynamic industry. This report incorporates data from leading companies like Ultra Health, Canopy Growth, and Cresco Labs, offering crucial competitive intelligence.

The global cannabidiol (CBD) extract market is experiencing robust growth, driven by increasing consumer awareness of CBD's potential health benefits and its expanding applications in various industries. The market, while still relatively young, shows significant promise, with a projected Compound Annual Growth Rate (CAGR) allowing for substantial market expansion over the next decade. Factors such as the legalization of CBD in several regions, coupled with increasing research validating its therapeutic properties for conditions like anxiety, pain, and sleep disorders, are key drivers. Furthermore, the versatility of CBD extracts, enabling their use in diverse products like skincare, edibles, and supplements, fuels market expansion. While regulatory uncertainties and varying legal frameworks across different geographies pose challenges, the overall positive trajectory suggests a promising future for the CBD extract market. Leading companies like Aphria, Aurora Cannabis, Canopy Growth, Maricann, Organigram, Cronos Group, Tikun Olam, and Tilray are actively shaping this market landscape through innovation and expansion strategies. The market segmentation reveals various product forms and application areas, each exhibiting unique growth patterns. The regional distribution of the market shows significant traction in North America and Europe, reflecting the higher acceptance and legalization of CBD products in these regions. Future growth will likely be influenced by the continuing evolution of regulatory landscapes, advancements in CBD extraction technologies, and increasing consumer demand fueled by positive clinical research and brand awareness campaigns. The forecast period of 2025-2033 reveals a substantial market expansion. Assuming a conservative CAGR of 15% (a reasonable estimate based on current market trends), and a 2025 market size of $5 billion (a plausible figure considering current market valuations and growth projections), the market value would reach approximately $16 billion by 2033. This substantial increase highlights the considerable investment opportunities and potential for market disruption within the CBD extract sector. However, consistent monitoring of regulatory changes, emerging competitor dynamics, and evolving consumer preferences will be crucial for sustained success within this dynamic market.

Medical cannabis made up the majority of the legal cannabis market in Europe in 2020. Sales of legal adult use cannabis totaled ***** million U.S. dollars in that year and are expected to grow to ***** million dollars by 2025.

The global cannabidiol (CBD) market is experiencing robust growth, projected to reach a market size of $1021 million in 2025, exhibiting a Compound Annual Growth Rate (CAGR) of 13.6%. This expansion is fueled by several key drivers. Increasing consumer awareness of CBD's potential health benefits, particularly in areas such as pain management, anxiety relief, and sleep improvement, is a significant factor. The burgeoning legalization and decriminalization of cannabis in various regions further contributes to market expansion, creating a more favorable regulatory environment for CBD products. The diversification of CBD product offerings, encompassing oils, edibles, topicals, and cosmetics, caters to a wider range of consumer preferences and needs, stimulating market growth. Furthermore, the rising integration of CBD into mainstream wellness and personal care routines drives increased demand across various application segments, including medicine, food and beverages, and cosmetics. While challenges exist, such as inconsistent regulations across jurisdictions and concerns regarding product purity and standardization, the overall market trajectory remains strongly positive. The market is segmented by application (medicine, food & beverages, cosmetics, other) and type (full-spectrum CBD oil, broad-spectrum CBD oil, CBD isolate). The medical application segment is expected to maintain significant growth driven by ongoing research and increasing acceptance of CBD as a complementary therapy. The food and beverage sector shows strong potential, with CBD-infused products gaining popularity. North America currently holds a dominant market share, due to early adoption and established regulatory frameworks in some areas, but Europe and Asia-Pacific are also exhibiting rapid growth, indicating a global expansion of the market. Major players such as Kazmira, KND Labs, Aurora Cannabis, and Charlotte's Web CBD are actively shaping market dynamics through product innovation and strategic expansion. The forecast period (2025-2033) suggests sustained growth driven by continued product development, market penetration in emerging regions, and ongoing research validating CBD's therapeutic potential. However, sustained vigilance regarding regulatory clarity and consistent quality control is crucial for maintaining consumer trust and driving long-term sustainable growth.

The Cannabidiol Market Report is Segmented by Source (Hemp and Marijuana), End Use (Pharmaceuticals, Wellness & Personal Use, and More), Product Form (Oils & Tinctures, Capsules & Softgels, and More), Distribution Channel (Hospital & Specialty Pharmacies, Retail Stores, and More), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

The global Cannabidiol (CBD) Isolates market is experiencing robust growth, driven by increasing consumer awareness of CBD's potential health benefits and its expanding applications across various sectors. The market size in 2025 is estimated at $369 million. While the exact CAGR is not provided, considering the rapid expansion of the broader CBD market and the specific advantages of isolates (high purity, versatility), a conservative estimate of the CAGR for the forecast period (2025-2033) would be between 15% and 20%. This suggests substantial market expansion, potentially reaching over $1.5 billion by 2033. Key drivers include the rising prevalence of chronic conditions like anxiety and pain, for which CBD is increasingly sought as a natural alternative. Further propelling growth are the burgeoning dietary supplement, cosmetic, and pharmaceutical sectors actively incorporating CBD isolates into their product lines. Trends indicate a preference for high-quality, rigorously tested isolates, driving demand for advanced extraction and purification technologies. However, regulatory uncertainties and fluctuating raw material prices pose significant restraints. The market is segmented by type (full-spectrum, broad-spectrum, isolates) and application (dietary supplements, food & beverages, e-cigarettes, cosmetics, pharmaceuticals). Major players are actively investing in research and development to improve production efficiency and explore new applications. The competitive landscape is characterized by a mix of established players and emerging companies, creating a dynamic market environment. North America currently dominates the market share, attributed to its early adoption of CBD products and advanced regulatory frameworks (although still evolving). However, Europe and Asia-Pacific are projected to witness significant growth due to increasing awareness, regulatory approvals, and expanding consumer bases. The continued expansion of research supporting the efficacy and safety of CBD isolates is crucial to further market penetration, particularly within the pharmaceutical sector. Challenges remain in standardizing product quality and ensuring consistent regulatory frameworks across different geographies. Nevertheless, the long-term outlook for the CBD isolates market remains positive, fueled by scientific advancements and growing consumer demand for natural wellness solutions.